Journal News

Rethinking how culture medium contributes to cellular function

Isha Dey
Jan. 4, 2022

Cell culture medium, as we know, contains a combination of growth factors and other components that help researchers grow cells in the lab. An important constituent in the growth medium is serum, an animal-derived complex of growth factors, amino acids and lipids, which provides nutrition to the growing cells. Researchers lack complete information on serum composition and its lot-to-lot variability but have studied the effects of some growth medium components on cellular metabolism. However, they do not yet understand fully the impact of the medium’s lipid content on cell function.

The powerhouse of human cells is mitochondria. An important component that determines mitochondrial function is cardiolipins, or CLs. These phospholipids located on the inner mitochondrial membrane are involved in mitochondrial bioenergetics and maintaining architecture of the mitochondrial membranes as well as in scavenging reactive oxygen species. However, cardiolipin composition is different in different tissues of the body, and because CLs play a central role in mitochondrial function, this means cells in different organs have varied mitochondrial activity.

To better understand the effect of nutrition, especially lipids, on mitochondrial CL composition and function, Markus Keller’s lab at the Medical University of Innsbruck in Austria cultured mammalian cells in lipid-free medium and then fed them with various types of lipids. Using mass spectrometry lipidomics and mathematical modeling, the authors were able to quantify the CL composition in the presence of different fatty acids in the growth medium.

Specifically, addition of linoleic acid to the medium altered 76% of the natural CL side chain composition compared to untreated medium. Addition of alpha linolenic acid and arachidonic acid also altered CL side chain composition significantly. Moreover, linoleic acid treatment increased the activity of the mitochondrial respiratory complex I, which is responsible for generating ATP and thus regulates normal functioning of a cell. The lab’s breakthrough findings were published in the Journal of Lipid Research.

Gregor Oemer, the first author on the paper, said an initial challenge of this project was finding cells that would grow without lipids, which are usually necessary for cell proliferation. “We got Panserin 401 (a serum-free medium) from a German biotech company and luckily got our HeLa cells to grow in this lipid-free medium,” he said.

The work was a collaborative effort. “We were in luck because Innsbruck is the home base for Oroboros, one of the most renowned respirometry companies,” Oemer said, “and thanks to Erich Gnaiger, the head, we collaborated for the respirometry assays.”

This project was a continuation of Oemer’s master’s thesis from the Keller lab. “Lipid metabolism is very complex but quite fascinating, and we don’t know much about it,” he said.

What struck Oemer most was how, by just altering the lipid intake, the researchers were able to influence critical cellular functions. He hopes the work raises awareness that variations in serum in cell culture medium may alter experimental data. This is especially important while studying diseases such as Barth syndrome, a genetic disorder characterized by abnormalities in mitochondrial cardiolipins.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Isha Dey

Isha Dey is a scientist at Thermo Fisher Scientific.

Related articles

From the journals: JLR
Swarnali Roy
From the journals: JLR
Swarnali Roy
From the journals: JLR
Nivedita Uday Hegdekar
From the journals: JLR
Clementine Adeyemi
From the journals: JLR
Lisa Learman & Laurel Oldach

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.